Total Payments
$164,372
2024 Payments
$32,151
Companies
16
Transactions
500
Medicare Patients
2,048
Medicare Billing
$410,591
Payment Breakdown by Category
Other$143,318 (87.2%)
Travel$11,329 (6.9%)
Food & Beverage$8,306 (5.1%)
Consulting$1,400 (0.9%)
Education$19.12 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $143,318 | 87 | 87.2% |
| Travel and Lodging | $11,329 | 56 | 6.9% |
| Food and Beverage | $8,306 | 354 | 5.1% |
| Consulting Fee | $1,400 | 1 | 0.9% |
| Education | $19.12 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $145,468 | 270 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $11,218 | 73 | $0 (2024) |
| Allergan, Inc. | $4,827 | 7 | $0 (2022) |
| IMPEL PHARMACEUTICALS INC. | $798.75 | 37 | $0 (2023) |
| Lundbeck LLC | $431.49 | 19 | $0 (2024) |
| Lilly USA, LLC | $372.73 | 21 | $0 (2023) |
| Amgen Inc. | $354.76 | 16 | $0 (2022) |
| Currax Pharmaceuticals LLC | $324.86 | 23 | $0 (2024) |
| PFIZER INC. | $221.91 | 13 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $117.28 | 11 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $32,151 | 101 | ABBVIE INC. ($31,313) |
| 2023 | $45,414 | 130 | ABBVIE INC. ($44,166) |
| 2022 | $52,131 | 162 | ABBVIE INC. ($46,539) |
| 2021 | $34,676 | 107 | AbbVie Inc. ($23,451) |
All Payment Transactions
500 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $29.96 | General |
| Category: NEUROLOGY | ||||||
| 12/06/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $25.71 | General |
| Category: Central Nervous System | ||||||
| 12/03/2024 | ABBVIE INC. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,925.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | ABBVIE INC. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.16 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | ABBVIE INC. | UBRELVY (Drug) | Travel and Lodging | In-kind items and services | $160.80 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $40.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $5.17 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $123.99 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $30.27 | General |
| Category: NEUROLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.14 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: PAIN | ||||||
| 10/22/2024 | ABBVIE INC. | QULIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,925.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Central Nervous System | ||||||
| 10/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.99 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | ABBVIE INC. | QULIPTA (Drug) | Travel and Lodging | In-kind items and services | $134.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $26.05 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | ABBVIE INC. | QULIPTA (Drug) | Travel and Lodging | In-kind items and services | $15.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $27.13 | General |
| Category: Central Nervous System | ||||||
| 09/26/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Central Nervous System | ||||||
| 09/24/2024 | ABBVIE INC. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,925.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.77 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $8.56 | General |
| Category: PAIN | ||||||
| 09/13/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $10.75 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 794 | 2,782 | $882,580 | $215,357 |
| 2022 | 12 | 421 | 1,228 | $366,553 | $91,957 |
| 2021 | 5 | 344 | 474 | $117,483 | $39,840 |
| 2020 | 9 | 489 | 752 | $199,550 | $63,437 |
Total Patients
2,048
Total Services
5,236
Medicare Billing
$410,591
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 59 | 630 | $247,042 | $62,410 | 25.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 68 | 587 | $223,119 | $48,082 | 21.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 214 | 551 | $144,138 | $40,752 | 28.3% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 44 | 64 | $48,000 | $12,465 | 26.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 70 | 84 | $29,652 | $9,044 | 30.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 59 | 157 | $39,112 | $8,450 | 21.6% |
| G0317 | Prolonged nursing facility evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualifi | Office | 2023 | 48 | 369 | $25,026 | $7,631 | 30.5% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 59 | 86 | $25,800 | $5,237 | 20.3% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 15 | 68 | $17,974 | $4,652 | 25.9% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 39 | 39 | $18,857 | $4,606 | 24.4% |
| 64505 | Injection of anesthetic agent, trigeminal nerve bundle | Office | 2023 | 11 | 31 | $23,700 | $4,110 | 17.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 30 | 30 | $13,500 | $3,999 | 29.6% |
| 62370 | Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | Office | 2023 | 39 | 43 | $11,610 | $2,400 | 20.7% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 39 | 43 | $15,050 | $1,519 | 10.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 140 | 335 | $76,840 | $25,043 | 32.6% |
| 99356 | Extended inpatient or observation hospital service, first hour | Office | 2022 | 35 | 282 | $74,930 | $16,484 | 22.0% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 22 | 174 | $45,993 | $10,197 | 22.2% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Office | 2022 | 18 | 117 | $45,879 | $10,136 | 22.1% |
| 99358 | Extended patient service without direct patient contact, first hour | Office | 2022 | 49 | 125 | $40,496 | $8,930 | 22.1% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 26 | 38 | $28,500 | $7,435 | 26.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 20 | 27 | $9,027 | $3,090 | 34.2% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 31 | 44 | $13,200 | $2,694 | 20.4% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Office | 2022 | 24 | 24 | $11,604 | $2,564 | 22.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 17 | 17 | $7,425 | $2,359 | 31.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 27 | 33 | $8,221 | $1,825 | 22.2% |
About Roger Chapman, FNP-C
Roger Chapman, FNP-C is a Nurse Practitioner healthcare provider based in Tyler, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2017. The National Provider Identifier (NPI) number assigned to this provider is 1750805941.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Roger Chapman, FNP-C has received a total of $164,372 in payments from pharmaceutical and medical device companies, with $32,151 received in 2024. These payments were reported across 500 transactions from 16 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($143,318).
As a Medicare-enrolled provider, Chapman has provided services to 2,048 Medicare beneficiaries, totaling 5,236 services with total Medicare billing of $410,591. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Tyler, TX
- Active Since 07/28/2017
- Last Updated 06/21/2018
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1750805941
Products in Payments
- UBRELVY (Drug) $79,602
- QULIPTA (Drug) $70,590
- AJOVY (Biological) $11,218
- Trudhesa (Drug) $798.75
- VYEPTI (Biological) $431.49
- NURTEC ODT (Drug) $412.55
- Aimovig (Biological) $354.76
- EMGALITY (Drug) $353.83
- CONTRAVE (Drug) $256.37
- BOTOX (Biological) $103.16
- ONZETRA XSAIL (Drug) $68.49
- Prialt (Drug) $58.67
- TOSYMRA (Drug) $34.61
- OSTEOCOOL RF ABLATION SYSTEM (Device) $28.63
- Senza (Device) $24.02
- REYVOW (Drug) $18.90
- Durolane (Device) $18.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Tyler
David Mccaskill, Fnp-C, Acnp, FNP-C, ACNP
Nurse Practitioner — Payments: $13,081
Nurse Practitioner $13,081
John Campbell, Fnp, FNP
Nurse Practitioner — Payments: $7,974
Nurse Practitioner $7,974
Mr. Francisco Rivera, Fnp,Acnp, FNP,ACNP
Nurse Practitioner — Payments: $7,776
Nurse Practitioner $7,776
Mrs. Constance Bentley, Aprn, APRN
Nurse Practitioner — Payments: $7,756
Nurse Practitioner $7,756
Kimberly Brown, Fnp, FNP
Nurse Practitioner — Payments: $7,552
Nurse Practitioner $7,552
David Stephens, Fnp-C, FNP-C
Nurse Practitioner — Payments: $7,479
Nurse Practitioner $7,479